1.B lymphoma Moloney murine leukemia virus insertion region 1: An oncogenic mediator in prostate cancer.
Qipeng LIU ; Qiaqia LI ; Sen ZHU ; Yang YI ; Qi CAO
Asian Journal of Andrology 2019;21(3):224-232
B lymphoma Moloney murine leukemia virus insertion region 1 (BMI1), a core member of polycomb repressive complex 1 (PRC1), has been intensely investigated in the field of cancer epigenetics for decades. Widely known as a critical regulator in cellular physiology, BMI1 is essential in self-renewal and differentiation in different lineages of stem cells. BMI1 also plays a significant role in cancer etiology for its involvement in pathological progress such as epithelial-mesenchymal transition (EMT) and cancer stem cell maintenance, propagation, and differentiation. Importantly, overexpression of BMI1 is predictive for drug resistance, tumor recurrence, and eventual therapy failure of various cancer subtypes, which renders the pharmacological targeting at BMI1 as a novel and promising therapeutic approach. The study on prostate cancer, a prevalent hormone-related cancer among men, has promoted enormous research advancements in cancer genetics and epigenetics. This review summarizes the role of BMI1 as an oncogenic and epigenetic regulator in tumor initiation, progression, and relapse of prostate cancer.
Animals
;
Gene Expression Regulation, Neoplastic
;
Humans
;
Lymphoma, B-Cell/genetics*
;
Male
;
Mice
;
Moloney murine leukemia virus/genetics*
;
Mutagenesis, Insertional/genetics*
;
Polycomb Repressive Complex 1/genetics*
;
Prostatic Neoplasms/genetics*
2.Prokaryotic expression and purification of moloney murine leukemia virus reverse transcriptase and verification of the activity.
Xiansong WANG ; Xuemei MA ; Yi SUN
Chinese Journal of Biotechnology 2008;24(5):903-906
To produce the reverse transcriptase of moloney murine leukemia virus (MMLV-RT) through gene recombination, MMLV-rt gene was amplified by polymerase chain reaction (PCR) with specifically designed primers bearing restriction enzyme sites. Five mutation sites increasing the solution of the target protein were introduced through Site-directed mutation. After verification by sequencing, the gene was cloned into the expression vector pET15b to construct the recombinant plasmid pET15b-MMLV-rt. Purified MMLV-RT was obtained by affinity chromatography (Ni3+-NTA beads). Molecular weight and purity of MMLV-RT were analyzed with SDS-PAGE. Enzyme activity was characterized with RT-PCR. We successfully constructed the recombinant plasmid pET15b-MMLV-rt and obtained the MMLV-RT fusion protein with 6His on the N-terminus. Recombinant protein was purified through Ni3+-NTA beads based affinity chromatography, the purity of which was 96%. The Activity of the enzyme was high. MMLV-RT of 96% purity was obtained with the prokaryotic expression technique, which serves as the basis for mass production of this enzyme.
Animals
;
Mice
;
Moloney murine leukemia virus
;
enzymology
;
genetics
;
RNA-Directed DNA Polymerase
;
biosynthesis
;
genetics
;
Recombinant Fusion Proteins
;
biosynthesis
;
genetics
;
metabolism
;
Recombination, Genetic